The purpose of this study is to evaluate the effect of Cetaphil® Restoraderm® skin restoring moisturizer in reducing the signs and symptoms of very dry atopic skin in young children. Subjects with atopic dermatitis (AD) in remission phase will be randomized to receive either Cetaphil® Restoraderm® skin restoring body wash only, or the same body wash in association with Cetaphil® Restoraderm® skin restoring moisturizer.
Two groups randomized in a ratio of \[1:1\] for a 12-week period Five study evaluation were planned: at Baseline, week 2, Week 4, Week8 and Week12
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
120
Department of Dermatology /Shenzhen Children's hospital
Shenzhen, Guangdong, China
Hunan Children's Hospital
Hunan, Hunan, China
XinHua Hospital
Yangpu, Shanghai Municipality, China
Department of Dermatology /Beijing Children's Hospital
Beijing, XI Cheng, China
Time to Relapse (Quantile 25%)
Time to relapse corresponds to date of relapse - date of baseline. Quantile 25% replaced the median time to relapse that was not reached.
Time frame: The duration between Baseline and the first AD relapse occurred (up to 89 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Philippine General Hospital
Manila, Ermita, Philippines
Asian Hospital and Medical Center
Manila, Muntinlupa City, Philippines
St. Luke's Medical Center
City of Taguig, Taguig City, Philippines
Jose R. Reyes Memorial Medical Center
Manila, Philippines